Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ISYNA1P1 is a pseudogene related to the ISYNA1 gene, which encodes the enzyme inositol-3-phosphate synthase 1, the rate-limiting enzyme in myo-inositol biosynthesis[5]. Pseudogenes like ISYNA1P1 do not produce functional proteins, and there is no evidence that ISYNA1P1 is translated or directly involved in any known cellular process or disease. It is not considered a therapeutic target, and no drugs, mechanisms, or biomarker roles are associated with this pseudogene[5]. The functional gene, ISYNA1, is an enzyme important in inositol biosynthesis and has been studied as a potential biomarker or target in certain cancers, but ISYNA1P1 is a non-functional relic with no demonstrated biological, pharmacological, or clinical relevance[1][3][4]. The presence of ISYNA1P1 is sometimes referenced in genome annotations, primarily as a sequence homolog with no known function[5]. The pseudogene can sometimes cause confusion with the functional gene, but it is essential to distinguish between ISYNA1 (functional) and ISYNA1P1 (pseudogene, nonfunctional)[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol-3-phosphate synthase 1 pseudogene 1 (ISYNA1P1).